Obsidian Therapeutics Inc. (OBX) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Obsidian Therapeutics Inc. (OBX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $17.0M, listed on NASDAQ, employing roughly 71 people, carrying a beta of 2.64 to the broader market. A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Led by Madan Jagasia, public since 2026-08-04.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for OBX as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.